Mostrar el registro sencillo del ítem

Artículo

dc.creatorRodríguez Villodres, Ángeles
dc.creatorMartín-Gandul, Ceciliaes
dc.creatorPeñalva, Germánes
dc.creatorGuisado Gil, Ana Belénes
dc.creatorCrespo-Rivas, Juan Carloses
dc.creatorPachón Ibáñez, María Eugeniaes
dc.creatorLepe Jiménez, José Antonioes
dc.creatorCisneros, José Migueles
dc.date.accessioned2022-11-15T12:36:48Z
dc.date.available2022-11-15T12:36:48Z
dc.date.issued2021-06-07
dc.identifier.citationRodríguez-Villodres, Á., Martín-Gandul, C., Peñalva, G., Guisado-Gil, A.B., Crespo-Rivas, J.C., Pachón-Ibáñez, M.E.,...,Cisneros, J.M. (2021). Prevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a review. Antibiotics, 10 (6). https://doi.org/10.3390/antibiotics10060680.
dc.identifier.issn2079-6382es
dc.identifier.urihttps://hdl.handle.net/11441/139442
dc.description.abstractElderly people confined to chronic care facilities face an increased risk of acquiring infections by multidrug-resistant organisms (MDROs). This review presents the current knowledge of the prevalence and risk factors for colonization by MDROs in long-term care facilities (LTCF), thereby providing a useful reference to establish objectives for implementing successful antimicrobial stewardship programs (ASPs). We searched in PubMed and Scopus for studies examining the prevalence of MDROs and/or risk factors for the acquisition of MDROs in LTCF. One hundred and thirty-four studies published from 1987 to 2020 were included. The prevalence of MDROs in LTCF varies between the different continents, where Asia reported the highest prevalence of extended-spectrum ß-lactamase (ESBL) Enterobacterales (71.6%), carbapenem resistant (CR) Enterobacterales (6.9%) and methicillin-resistant Staphylococcus aureus (MRSA) (25.6%) and North America the highest prevalence to MDR Pseudomonas aeruginosa (5.4%), MDR Acinetobacter baumannii (15.0%), vancomycin-resistant Enterococcus spp. (VRE) (4.0%), and Clostridioides difficile (26.1%). Furthermore, MDRO prevalence has experienced changes over time, with increases in MDR P. aeruginosa and extended spectrum ß-lactamase producing Enterobacterales observed starting in 2015 and decreases of CR Enterobacterales, MDR A. baumannii, VRE, MRSA and C. difficile. Several risk factors have been found, such as male sex, chronic wounds, the use of medical devices, and previous antibiotic use. The last of these aspects represents one of the most important modifiable factors for reducing colonization with MDROs through implementing ASPs in LTCF.es
dc.formatapplication/pdfes
dc.format.extent22 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofAntibiotics, 10 (6).
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMultidrug-resistant organismes
dc.subjectLong term care facilitieses
dc.subjectNursing homeses
dc.subjectPrevalencees
dc.subjectRisk factorses
dc.subjectAntimicrobial stewardshipes
dc.titlePrevalence and risk factors for multidrug-resistant organisms colonization in long-term care facilities around the world: a reviewes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Microbiologíaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.projectIDCM18/00122es
dc.relation.projectIDCM19/00029es
dc.relation.projectIDREIPI RD16/0016/0009es
dc.relation.projectIDPI17-02195es
dc.relation.projectIDREIPI RD16/0016/0001es
dc.relation.projectIDRD16/0016/0009es
dc.relation.publisherversionhttps://www.mdpi.com/2079-6382/10/6/680es
dc.identifier.doi10.3390/antibiotics10060680es
dc.journaltitleAntibioticses
dc.publication.volumen10es
dc.publication.issue6es
dc.contributor.funderEuropean Development Regional Fund 'A way to achieve Europe' ERDF, Spanish Network for the Research in Infectious Diseases, REIPI RD16/0016/0009es
dc.contributor.funderEuropean Development Regional Fund "A way to achieve Europe"es
dc.contributor.funderEuropean Development Regional Fund "A way to achieve Europe", Operative program Intelligent Growth 2014-2020es
dc.contributor.funderInstituto de Salud Carlos III, PI17-02195es
dc.contributor.funderInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad, Spanish Network for Research in Infectious Diseases, REIPI RD16/0016/0001es
dc.contributor.funderInstituto de Salud Carlos III, Subdireccion General de Redes y Centros de InvestigacionCooperativa, Ministry of Economy, Industry and Competitiveness, Spanish Network for Research in Infectious Diseases, REIPI RD16/0016/0001; RD16/0016/0009es
dc.contributor.funderInstituto de Salud Carlos III, the Spanish Ministry of Economy, Industry, and Competitiveness, PI17-02195es
dc.contributor.funderPlan Nacional de I+D+i 2013-2016es
dc.contributor.funderServicio Andaluz de Salud, Junta de Andalucia, Spain, C1-0038-2019es
dc.contributor.funderSubprograma Rio Hortega, Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Ciencia, Innovacion y Universidades, Spaines

FicherosTamañoFormatoVerDescripción
Prevalence and risk factors for ...2.007MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Atribución 4.0 Internacional